Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2018-10-19

First treatment for rare inherited muscle contraction disorders

View source ↗

Summary

EMA announces the first treatment for rare inherited muscle contraction disorders, marking a milestone in addressing these conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications